News
-
26.10.2021Captor Therapeutics to Present at the 4th Annual Targeted Protein Degradation SummitmoreDr. Michał Walczak will present on 28 October 2021
-
15.10.2021Captor Therapeutics presents H1 2021 financial results and provides business updatemoreCaptor presented data from its H1 2021 report during the WSE Innovation Day
-
11.10.2021GPW Innovation DaymoreCaptor Therapeutics will be present during upcoming Warsaw Stock Exchange Innovation Day
-
06.10.2021Zaproszenie na spotkanie z przedstawicielami Spółkimorecelem prezentacji i omówienia wyników finansowych za okres H1 2021. -
28.09.2021Captor Therapeutics reveals pipeline project targeting the undrugged target MCL-1moreThe Company today announced key preclinical data and revealed the identity of the drug target
-
14.09.2021Captor Therapeutics to Present at the 3rd European Protein Degradation Congress in SeptembermoreDr. Tom Shepherd will present on 21st September, 2021
-
30.08.2021Collaboration with LifeSci AdvisorsmoreCaptor Therapeutics S.A. has entered into an agreement with LifeSci Advisors LLC
-
29.06.2021Appointment of Radosław Krawczyk as Chief Financial OfficermoreThe Supervisory Board has appointed Radosław Krawczyk to the Company's Management Board and entrusted him with the function of CFO
-
22.06.2021Resignation of the CFO and the succession planmoreAleksandra Skibińska resigned from the position of the Member of the Management Board and Chief Financial Officer
-
16.04.2021WSE listing ceremony invitationmoreon the Warsaw Stock Exchange